Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $104.8400 (-1%) ($104.5100 - $105.9400) on Tue. Mar. 23, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.57% (three month average) | RSI | 46 | Latest Price | $104.8400(-1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -1.1% a day on average for past five trading days. | Weekly Trend | ABBV declines -1% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(45%) SPLV(36%) VYM(32%) XLP(32%) DIA(30%) | Factors Impacting ABBV price | ABBV will decline at least -0.785% in a week (0% probabilities). VIXM(-21%) UUP(-10%) VXX(-3%) TLT(-1%) KWEB(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.785% (StdDev 1.57%) | Hourly BBV | 0.4 () | Intraday Trend | -0.6% | | | |
|
Resistance Level | $106.96 | 5 Day Moving Average | $104.59(0.24%) | 10 Day Moving Average | $106.72(-1.76%) | 20 Day Moving Average | $106.96(-1.98%) | To recent high | -6.9% | To recent low | 2.5% | Market Cap | $184.967b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |